zepbound tirzepatide eli lilly weight-loss drug appears to suppress binge-eating signal, small study finds FDA approval for Zepbound (tirzepatide)

In contrast to the lack of brain entry of dopamine in vivo [68], our results with the targeted dopamine-nanoformulation using the BBB model combined with midbrain organoids indicate that the nanoformulation may help dopamine to reach the brain tissue after BBB penetration

Annual review of public health, 38, 295313

Owing to embryonic transparency, high-throughput capability, and genetic conservation of inflammatory pathways with humans, zebrafish are a powerful model for pharmacodynamic evaluation of natural products

Physicians rely heavily on detailed procedural information and typically assume that a dentist requesting clearance has already completed a thorough assessment

We screen every patient at our Rockaway and Morristown locations for personal and family histories of thyroid C-cell tumors